Vyome Holdings Inc. , a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets.
Vyome Holdings stock last closed at $2.13, down 0.93% from the previous day, and has decreased 95.27% in one year. It has underperformed other stocks in the Medical Devices industry by 0.29 percentage points. Vyome Holdings stock is currently +21.71% from its 52-week low of $1.75, and -96.95% from its 52-week high of $69.77.
As of Apr 2, 2026, there are 7.02M shares of HIND outstanding. The market value of HIND is $14.95M. In the past 24 hours, 5100 HIND shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy HIND stock.
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, the next step is to fill out some personal details so you are able to buy HIND today.
Now that you have finished signing up on the best stock market app, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help depositing funds into your new brokerage account.
Once you have identified the best place to buy Vyome Holdings stock, it's absolutely critical to research their stock before you invest, so you can understand the risk as well as the upside.
WallStreetZen was built to help average investors do more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on HIND's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge HIND's intrinsic value.
Using relative valuations methods:
You can do more valuation research on HIND's stock here.
You can dive deeper into what analysts are saying on the Vyome Holdings stock forecast page.
Last year, HIND revenue was $319.71k. During the past five year, HIND's revenue has gone up by -50.98% per year. This was slower than the Medical Devices industry average of 11.4%.
Find out more about HIND's earnings and revenue performance here.
Over the last year, executives and large shareholders at HIND have not bought or sold any shares.
Dig into more about who owns HIND shares here.
No, Vyome Holdings doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two main options:
Hit the Open Trade button and eToro will execute your order.
If you need additional info about investing in stocks on eToro, click the how to video below:
Now that you own some HIND shares, you'll want to keep up with your new company.
Start a watchlist to track the most important metrics related to your HIND stock.
To summarize, here are the 6 steps you need to take to buy Vyome Holdings stock right now:
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get updates on your investment in Vyome Holdings, hit the button below to create your watchlist.